semaglutide alcohol use disorder study 🚨 Can a diabetes drug help treat cravings? 🧪 (Ozempic), known for managing diabetes and aiding weight loss, is showing promise in reducing alcohol cravings. But is it the future As GLP-1 use surges among

, () () (), (Sun, 2015)

Pruritus was reported in 4%, 2%, and 2% of patients (including adolescents) receiving topiramate 50 mg/day, 100 mg/day, and 200 mg/day, respectively, for migraines in placebo-controlled (2%) clinical trials

A 2006 study published in the Journal of Clinical Endocrinology and Metabolism found that CJC-1295 produced sustained, dose-dependent increases in both GH and IGF-1 levels

Obesity is also linked to 6578% of hypertension cases (Garrison et al

The consistent tolerability profile across studies, with gastrointestinal symptoms being the most frequently reported adverse effects, reinforces the clinical feasibility of repurposing GLP-1RAs in this context